{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:08:26Z","timestamp":1762506506457},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Use of hydroxyethyl starch (HES) in septic patients is reported to increase the mortality and incidence of renal replacement therapy (RRT). However, whether or not use of HES would induce the same result in non-septic patients in the intensive care unit (ICU) remains unclear. The objective of this meta-analysis was to evaluate 6% HES versus other fluids for non-septic ICU patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Randomized controlled trials (RCTs) were searched from Pubmed, OvidSP, Embase database and Cochrane Library, published before November, 2013. A meta-analysis was made on the effect of 6% HES versus other fluids for non-septic ICU patients, including mortality, RRT incidence, bleeding volume, red blood cell (RBC) transfusion and fluid application for non-septic patients in ICU.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-two RCTs were included, involving 6,064 non-septic ICU patients. Compared with the other fluids, 6% HES was not associated with decreased overall mortality (RR\u2009=\u20091.03, 95%CI: 0.09 to 1.17; <jats:italic>P<\/jats:italic>\u2009=\u20090.67; <jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup>\u2009=\u20090). There was no significant difference in RRT incidence, bleeding volume and red blood cell transfusion between 6% HES group and the other fluid groups. However, patients in HES group received less total intravenous fluids than those receiving crystalloids during the first day in ICU (SMD\u2009=\u2009\u22120.84; 95%CI: \u22121.39 to \u22120.30; <jats:italic>P<\/jats:italic>\u2009=\u20090.003, <jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup>\u2009=\u200974%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This meta-analysis found no increased mortality, RRT incidence, bleeding volumes or RBC transfusion in non-septic ICU patients, but the sample sizes were small and the studies generally were of poor quality.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-015-0833-9","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T14:42:30Z","timestamp":1425048150000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"19","author":[{"given":"Bin","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongrong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"833_CR1","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/cc9293","volume":"14","author":"S Finfer","year":"2010","unstructured":"Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care. 2010;14:R185.","journal-title":"Crit Care"},{"key":"833_CR2","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1213\/01.ANE.0000061460.59320.B0","volume":"96","author":"DR McIlroy","year":"2003","unstructured":"McIlroy DR, Kharasch ED. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg. 2003;96:1572\u20137.","journal-title":"Anesth Analg."},{"key":"833_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/ALN.0b013e3181a7ec82","volume":"111","author":"M Westphal","year":"2009","unstructured":"Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: different products\u2013different effects. Anesthesiology. 2009;111:187\u2013202.","journal-title":"Anesthesiology."},{"key":"833_CR4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00540-010-1034-y","volume":"24","author":"TT Niemi","year":"2010","unstructured":"Niemi TT, Miyashita R, Yamakage M. Colloid solutions: a clinical update. J Anesth. 2010;24:913\u201325.","journal-title":"J Anesth."},{"key":"833_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","volume":"358","author":"FM Brunkhorst","year":"2008","unstructured":"Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125\u201339.","journal-title":"N Engl J Med."},{"key":"833_CR6","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","volume":"367","author":"JA Myburgh","year":"2012","unstructured":"Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901\u201311.","journal-title":"N Engl J Med."},{"key":"833_CR7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","volume":"367","author":"A Perner","year":"2012","unstructured":"Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, et al. Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis. N Engl J Med. 2012;367:124\u201334.","journal-title":"N Engl J Med."},{"key":"833_CR8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jama.2013.430","volume":"309","author":"R Zarychanski","year":"2013","unstructured":"Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309:678\u201388.","journal-title":"JAMA."},{"key":"833_CR9","first-page":"CD007594","volume":"7","author":"TC Mutter","year":"2013","unstructured":"Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 2013;7:CD007594.","journal-title":"Cochrane Database Syst Rev."},{"key":"833_CR10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00134-013-2840-0","volume":"39","author":"DJ Gattas","year":"2013","unstructured":"Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S. Fluid resuscitation with 6% hydroxyethyl starch (130\/0.4 and 130\/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med. 2013;39:558\u201368.","journal-title":"Intensive Care Med."},{"key":"833_CR11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00134-012-2472-9","volume":"38","author":"K Reinhart","year":"2012","unstructured":"Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med. 2012;38:368\u201383.","journal-title":"Intensive Care Med."},{"key":"833_CR12","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/jama.2013.280502","volume":"310","author":"D Annane","year":"2013","unstructured":"Annane D, Siami S, Jaber S, Martin C, Elatrous S, Decl\u00e8re AD, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA. 2013;310:1809\u201317.","journal-title":"JAMA."},{"key":"833_CR13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/ALN.0b013e31827e5569","volume":"118","author":"C Martin","year":"2013","unstructured":"Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130\/0.4 on renal function in surgical patients. Anesthesiology. 2013;118:387\u201394.","journal-title":"Anesthesiology."},{"key":"833_CR14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/bja\/aet303","volume":"112","author":"MA Gillies","year":"2014","unstructured":"Gillies MA, Habicher M, Jhanji S, Sander M, Mythen M, Hamilton M, et al. Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis. Br J Anaesth. 2014;112:25\u201334.","journal-title":"Br J Anaesth"},{"key":"833_CR15","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0140-6736(96)07588-5","volume":"348","author":"ML Cittanova","year":"1996","unstructured":"Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet. 1996;348:1620\u20132.","journal-title":"Lancet."},{"key":"833_CR16","unstructured":"Julian PT Higgins SG. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. 2011: Available at:http:\/\/handbook.cochrane.org."},{"key":"833_CR17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews andmeta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264\u20139.","journal-title":"Ann Intern Med."},{"key":"833_CR18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1053\/jhep.2002.31354","volume":"35","author":"R Ba\u00f1ares","year":"2002","unstructured":"Ba\u00f1ares R, Albillos A, Rinc\u00f3n D, Alonso S, Gonz\u00e1lez M, Ruiz-del-Arbol L, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology. 2002;35:609\u201315.","journal-title":"Hepatology."},{"key":"833_CR19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol."},{"key":"833_CR20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med."},{"key":"833_CR21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ."},{"key":"833_CR22","first-page":"31","volume":"19","author":"SJ Ley","year":"1990","unstructured":"Ley SJ, Miller K, Skov P, Preisig P. Crystalloid versus colloid fluid therapy after cardiac surgery. Heart Lung. 1990;19:31\u201340.","journal-title":"Heart Lung."},{"key":"833_CR23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1213\/01.ANE.0000175216.53374.27","volume":"101","author":"PJ Van der Linden","year":"2005","unstructured":"Van der Linden PJ, De Hert SG, Deraedt D, Cromheecke S, De Decker K, De Paep R, et al. Hydroxyethyl starch 130\/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg. 2005;101:629\u201334.","journal-title":"Anesth Analg."},{"key":"833_CR24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/bjs.5726","volume":"94","author":"A Mahmood","year":"2007","unstructured":"Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg. 2007;94:427\u201333.","journal-title":"Br J Surg."},{"key":"833_CR25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1017\/S026502150800447X","volume":"25","author":"G Godet","year":"2008","unstructured":"Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P. Safety of HES 130\/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol. 2008;25:986\u201394.","journal-title":"Eur J Anaesthesiol"},{"key":"833_CR26","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1213\/ane.0b013e3181aed54f","volume":"109","author":"A Mukhtar","year":"2009","unstructured":"Mukhtar A, Aboulfetouh F, Obayah G, Salah M, Emam M, Khater Y, et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anesth Analg. 2009;109:924\u201330.","journal-title":"Anesth Analg."},{"key":"833_CR27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/0218492309338101","volume":"17","author":"JS Ooi","year":"2009","unstructured":"Ooi JS, Ramzisham AR, Zamrin MD. Is 6% hydroxyethyl starch 130\/0.4 safe in coronary artery bypass graft surgery? Asian Cardiovasc Thoracic Ann. 2009;17:368\u201372.","journal-title":"Asian Cardiovasc Thoracic Ann"},{"key":"833_CR28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1213\/ane.0b013e31818c1282","volume":"108","author":"AA Schramko","year":"2009","unstructured":"Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg. 2009;108:30\u20136.","journal-title":"Anesth Analg."},{"key":"833_CR29","first-page":"584","volume":"76","author":"YS Choi","year":"2010","unstructured":"Choi YS, Shim JK, Hong SW, Kim JC, Kwak YL. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130\/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol. 2010;76:584\u201391.","journal-title":"Minerva Anestesiol."},{"key":"833_CR30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/bja\/aeq084","volume":"104","author":"A Schramko","year":"2010","unstructured":"Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: A prospective randomized trial. Br J Anaesth. 2010;104:691\u20137.","journal-title":"Br J Anaesth."},{"key":"833_CR31","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1253\/circj.CJ-11-0404","volume":"75","author":"JS Lee","year":"2011","unstructured":"Lee JS, Ahn SW, Song JW, Shim JK, Yoo KJ. lan Kwak Y. Effect of hydroxyethyl starch 130\/0.4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet Therapy undergoing off-pump coronary artery bypass graft surgery. Circ J. 2011;75:2397\u2013402.","journal-title":"Circ J."},{"key":"833_CR32","first-page":"1458","volume":"124","author":"J Yang","year":"2011","unstructured":"Yang J, Wang WT, Yan LN, Xu MQ, Yang JY. Alternatives to albumin administration in hepatocellular carcinoma patients undergoing hepatectomy: An open, randomized clinical trial of efficacy and safety. Chin Med J. 2011;124:1458\u201364.","journal-title":"Chin Med J."},{"key":"833_CR33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.5830\/CVJA-2012-026","volume":"23","author":"SM Alavi","year":"2012","unstructured":"Alavi SM, Baharvand Ahmadi B, Baharestani B, Babaei T. Comparison of the effects of gelatin, Ringer\u2019s solution and a modern hydroxyl ethyl starch solution after coronary artery bypass graft surgery. Cardiovasc J Afr. 2012;23:428\u201331.","journal-title":"Cardiovasc J Afr."},{"key":"833_CR34","unstructured":"Nagpal D, NCT00964015. Starch or Saline After Cardiac Surgery (SSACS) trial. Personal Communication. 2012."},{"key":"833_CR35","first-page":"140","volume":"17","author":"DM Kimenai","year":"2013","unstructured":"Kimenai DM, Bastianen G, Daane CR, Megens-Bastiaanse CM, Van Der Meer NJM, Scohy TV, et al. Effect of colloids Gelatin and HES 130\/0.4 on blood coagulation in cardiac surgery patients: A randomised controlled trial. Perfusion. 2013;17:140\u20131.","journal-title":"Perfusion."},{"key":"833_CR36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00003246-199404000-00015","volume":"22","author":"SC Beards","year":"1994","unstructured":"Beards SC, Watt T, Edwards JD, Nightingale P, Farragher EB. Comparison of the hemodynamic and oxygen transport responses to modified fluid gelatin and hetastarch in critically ill patients: a prospective, randomized trial. Crit Care Med. 1994;22:600\u20135.","journal-title":"Crit Care Med."},{"key":"833_CR37","first-page":"333","volume":"22","author":"J Chen","year":"2006","unstructured":"Chen J, Han CM, Xia SC, Tang ZJ, Su SJ. Evaluation of effectiveness and safety of a new hydroxyethyl starch used in resuscitation of burn shock. Zhonghua Shao Shang Za Zhi. 2006;22:333\u20136.","journal-title":"Zhonghua Shao Shang Za Zhi."},{"key":"833_CR38","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/EJA.0b013e32833b3504","volume":"27","author":"T Gondos","year":"2010","unstructured":"Gondos T, Marjanek Z, Ulakcsai Z, Szabo Z, Bogar L, Karolyi M, et al. Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. Eur J Anaesthesiol. 2010;27:794\u2013800.","journal-title":"Eur J Anaesthesiol."},{"key":"833_CR39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1757-7241-18-29","volume":"18","author":"BE Heradstveit","year":"2010","unstructured":"Heradstveit BE, Guttormsen AB, Langorgen J, Hammersborg SM, Wentzel-Larsen T, Fanebust R, et al. Capillary leakage in post-cardiac arrest survivors during therapeutic hypothermia - a prospective, randomised study. Scand J Trauma Resusc Emerg Med. 2010;18:29.","journal-title":"Scand J Trauma Resusc Emerg Med."},{"key":"833_CR40","first-page":"361","volume":"25","author":"MT Inal","year":"2010","unstructured":"Inal MT, Memis D, Karamanlioglu B, Sut N. Effects of polygeline and hydroxyethyl starch solutions on liver functions assessed with LIMON in hypovolemic patients. J Crit Care. 2010;25:361. e1\u20135.","journal-title":"J Crit Care"},{"key":"833_CR41","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/MPA.0b013e3182217f17","volume":"40","author":"XJ Du","year":"2011","unstructured":"Du XJ, Hu WM, Xia Q, Huang ZW, Chen GY, Jin XD, et al. Hydroxyethyl starch resuscitation reduces the risk of intra-abdominal hypertension in severe acute pancreatitis. Pancreas. 2011;40:1220\u20135.","journal-title":"Pancreas."},{"key":"833_CR42","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/bja\/aer229","volume":"107","author":"MFM James","year":"2011","unstructured":"James MFM, Michell WL, Joubert IA, Nicol AJ, Navsaria PH, Gillespie RS. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: The FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth. 2011;107:693\u2013702.","journal-title":"Br J Anaesth."},{"key":"833_CR43","doi-asserted-by":"crossref","first-page":"f839","DOI":"10.1136\/bmj.f839","volume":"346","author":"N Haase","year":"2013","unstructured":"Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, et al. Hydroxyethyl starch 130\/0.38\u20130.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ. 2013;346:f839.","journal-title":"BMJ"},{"key":"833_CR44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJMra032401","volume":"351","author":"RW Schrier","year":"2004","unstructured":"Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351:159\u201369.","journal-title":"N Engl J Med."},{"key":"833_CR45","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/01.RES.0000065917.53950.75","volume":"92","author":"BM Van den Berg","year":"2003","unstructured":"Van den Berg BM, Vink H, Spaan JA. The endothelial glycocalyx protects against myocardial edema. Circ Res. 2003;92:592.","journal-title":"Circ Res."},{"key":"833_CR46","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/SHK.0b013e318157e926","volume":"29","author":"X Marechal","year":"2008","unstructured":"Marechal X, Favory R, Joulin O, Montaigne D, Hassoun S, Decoster B, et al. Endothelial Glycocalix damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock. 2008;29:572.","journal-title":"Shock."},{"key":"833_CR47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jss.2009.04.034","volume":"165","author":"J Steppan","year":"2011","unstructured":"Steppan J, Hofer S, Funke B, Brenner T, Henrich M, Martin E, et al. Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix. J Surg Res. 2011;165:136\u201341.","journal-title":"J Surg Res."},{"key":"833_CR48","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00134-013-2863-6","volume":"39","author":"A Patel","year":"2013","unstructured":"Patel A, Waheed U, Brett SJ. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130\/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med. 2013;39:811\u201322.","journal-title":"Intensive Care Med."},{"key":"833_CR49","first-page":"CD000567","volume":"2","author":"P Perel","year":"2013","unstructured":"Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2013;2:CD000567.","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-0833-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-015-0833-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-0833-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-0833-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T09:41:59Z","timestamp":1627897319000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-015-0833-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1186\/s13054-015-0833-9","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"6 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"92"}}